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It has been highlighted that the original article \[[@CR1]\], published 21 February 2018, contained some errors in Table 3. This correction article shows the correct version of Table [3](#Tab1){ref-type="table"} and the changes that were made.Table 3The prevalence of peripheral neuropathy among patients with type 2 diabetes mellitus in Jordan according to relevant socio-demographic, clinical and laboratory characteristicsVariablesPeripheral neuropathyP valueYes\
n = 396No\
n = 607Gender0.137 Male201 (41.9)279 (58.1) Female195 (37.3)328 (62.7)Age (year)\< 0.001 \< 5023 (17.4)109 (82.6) 50--69269 (38.9)423 (61.1) ≥ 70104 (58.1)75 (41.9)Marital status0.777 Single/divorced/widowed52 (40.6)76 (59.4) Married344 (39.3)531 (60.7)Working status\< 0.001 Unemployed175 (50.9)169 (49.1) Employed83 (29.6)197 (70.4) Retired138 (36.4)241 (63.6)Physical activity\< 0.001 Regular29 (31.5)63 (68.5) Not regular72 (25)216 (75) No physical activity295 (47.4)328 (52.6)Family history of diabetes0.014 Present356 (41)513(59) Absent40 (29.9)94 (70.1)Regular visit to treating physicians\< 0.001 Yes342 (37.3)575 (62.7) No54 (62.8)32 (37.2)Body mass index (kg/m^2^)0.052 Normal32 (37.6)53 (62.4) Over weight103 (34.1)199 (65.9) Obese261 (42.4)355 (57.6)Duration of diabetes (year)\< 0.001 \< 529 (8.7)304 (91.3) 5--11139 (39)217 (61) ≥ 12288 (72.6)86 (27.4)Having hypertension\< 0.001 Yes374 (43.5)486 (56.5) No22 (15.4)121 (84.6)Nephropathy\< 0.001 Yes65 (69.1)29 (30.9) No331 (36.4)578 (63.6)Cardiovascular disease\< 0.001 Yes210 (54.8)173 (45.2) No186 (30)434 (70)Dyslipidemia\< 0.001 Yes381 (43)505 (57) No15 (12.8)102 (87.2)Retinopathy\< 0.001 Yes132 (67.3)64 (32.7) No264 (32.7)543 (67.3)Type of treatment\< 0.001 Insulin only77 (60.2)51 (39.8) Oral hypoglycemia agents only120 (22.8)407 (77.2) Oral hypoglycemia agents and insulin199 (57.2)149 (42.8)HbA1c (%)\< 0.001 Controlled \< 7%96 (22.7)326 (77.3) Uncontrolled ≥ 7%300 (51.6)281 (48.4)

**Changes:** A labeling error in Table [3](#Tab1){ref-type="table"} was corrected (Neuropathy status was replaced by Peripheral neuropathy).\[Without DPN n = 607 (100%)\] was replaced by (Yes n = 396).\[With DPN n = 396 (100%)\] was replaced by (No n = 607).\[Age group (year): (mean ± SD)\] was replaced by \[Age (year)\], and the mean age was removed from the table.\[Body mass index (BMI) (kg/m^2^): (mean ± SD)\] was replaced by \[Body mass index (kg/m^2^)\] and the mean BMI was removed.\[Duration of diabetes (year): (mean ± SD)\] was replaced by \[Duration of diabetes (year)\] and the mean duration was removed.SBP mmHg (mean ± SD) DBP mmHg (mean ± SD) was removed.All these were removed TC (mean ± SD), LDL (mean ± SD), HDL (mean ± SD).\[HbA1C (%): (mean ± SD)\] was replaced by \[HbA1c (%)\], and the mean HbA1c was removed from the table.

The original article can be found online at 10.1186/s13098-018-0309-6.
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